Risks, Side Effects, and Unknowns (So Far) Time for the part most articles gloss over
McGraw-Hill / Lange McCulloch DK (2014): Management of persistent hyperglycemia in type 2 diabetes mellitus
If only a body scanner is available at that checkpoint, you may request a pat-down instead
Review of the Key Results from the Swedish Obese Subjects (SOS) TrialA Prospective Controlled Intervention Study of Bariatric Surgery
Study findings showed that oral semaglutide use was associated with significant improvements in blood sugar control, reduced body weight, improved several lipid markers, and reduced alanine aminotransferase (ALT), a liver enzyme marker, in study participants
These gastrointestinal issues are similar to those seen with other GLP-1 receptor agonists but may be more pronounced due to the dual-action nature of Tirzepatide